Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Hall

Showing results (141-150 of 387) with videos related to

Pageof 39
Sort By:
Journal of Inorganic Biochemistry|April 21, 2006
XANES investigation of the Co oxidation state in solution and in cancer cells treated with Co(III) complexesPaul D Bonnitcha, Matthew D Hall, Clare K Underwood, et al.
Molecular Cancer Therapeutics|November 8, 2014
The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicityKi-Eun Chang, Bih-Rong Wei, James P Madigan, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 8, 2018
Better living through chemistry: Addressing emerging antibiotic resistanceNathan P Coussens, Ashley L Molinaro, Kayla J Culbertson, et al.
Assay and Drug Development Technologies|June 25, 2009
A dual-fluorescence high-throughput cell line system for probing multidrug resistanceKyle R Brimacombe, Matthew D Hall, Douglas S Auld, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2013
Overlapping substrate and inhibitor specificity of human and murine ABCG2Joshua Bakhsheshian, Matthew D Hall, Robert W Robey, et al.
Molecular Pharmaceutics|May 11, 2012
The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatinDing-Wu Shen, Lynn M Pouliot, Jean-Pierre Gillet, et al.
Molecular Cancer Therapeutics|March 21, 2022
GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt SignalingJiajia Pan, Nan Li, Alex Renn, et al.
Annals of Surgical Oncology|May 10, 2015
Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal CancerMatthew D Hall, Timothy E Schultheiss, David D Smith, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactionsKyle M Flickinger, Kelli M Wilson, Nicholas J Rossiter, et al.
The Journal of Infectious Diseases|December 1, 2020
Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay PerformanceCarleen Klumpp-Thomas, Heather Kalish, Jennifer Hicks, et al.
Pageof 39

Showing results (141-150 of 387) with videos related to

Sort By:
Pageof 39
Journal of Inorganic Biochemistry|April 21, 2006
XANES investigation of the Co oxidation state in solution and in cancer cells treated with Co(III) complexesPaul D Bonnitcha, Matthew D Hall, Clare K Underwood, et al.
Molecular Cancer Therapeutics|November 8, 2014
The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicityKi-Eun Chang, Bih-Rong Wei, James P Madigan, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 8, 2018
Better living through chemistry: Addressing emerging antibiotic resistanceNathan P Coussens, Ashley L Molinaro, Kayla J Culbertson, et al.
Assay and Drug Development Technologies|June 25, 2009
A dual-fluorescence high-throughput cell line system for probing multidrug resistanceKyle R Brimacombe, Matthew D Hall, Douglas S Auld, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2013
Overlapping substrate and inhibitor specificity of human and murine ABCG2Joshua Bakhsheshian, Matthew D Hall, Robert W Robey, et al.
Molecular Pharmaceutics|May 11, 2012
The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatinDing-Wu Shen, Lynn M Pouliot, Jean-Pierre Gillet, et al.
Molecular Cancer Therapeutics|March 21, 2022
GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt SignalingJiajia Pan, Nan Li, Alex Renn, et al.
Annals of Surgical Oncology|May 10, 2015
Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal CancerMatthew D Hall, Timothy E Schultheiss, David D Smith, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactionsKyle M Flickinger, Kelli M Wilson, Nicholas J Rossiter, et al.
The Journal of Infectious Diseases|December 1, 2020
Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay PerformanceCarleen Klumpp-Thomas, Heather Kalish, Jennifer Hicks, et al.
Pageof 39